---
title: 'Director / Senior Director, Clinical Scientist (Part-time, Temp) at Superluminal Medicines, Inc.'
canonical: 'https://feeny.ai/job/director-senior-director-clinical-scientist-part-time-temp-superluminal-7zsgx8tfjybc'
type: 'job'
last_seen: '2026-09-16'
---

# Director / Senior Director, Clinical Scientist (Part-time, Temp) at Superluminal Medicines, Inc.

- **Company:** Superluminal Medicines, Inc.
- **Location:** Boston, MA
- **Posted:** 2026-09-15
- **Last confirmed live:** 2026-09-16
- **Apply:** https://job-boards.greenhouse.io/superluminalrx/jobs/5391165008

## Job description

About Superluminal Medicines:

Superluminal Medicines is a generative biology and chemistry company revolutionizing the speed and accuracy of how small molecule medicines are created. The Company’s platform aims to create candidate-ready compounds with unprecedented speed using a combination of deep biology, computational and medicinal chemistry, machine learning, and proprietary big data infrastructure. We are expanding the team of talented scientists who seek to build the future of small molecule drug discovery with creativity and innovation.

## The Role

Superluminal Medicines is seeking a detail-oriented and collaborative Clinical Scientist to join our team 15-20 hours per week. Reporting directly to the Executive Director of Clinical Development, you will play a critical role in the scientific design, execution, and data-driven evaluation of our clinical trial programs.

You will serve as a core scientific engine within the clinical team, bridging the gap between non-clinical findings and clinical execution. Your work will directly shape protocol design, safety monitoring, data analysis, and the synthesis of scientific evidence to advance our pipeline through Phase I–IV trials safely and effectively.

## Key Responsibilities

- Protocol & Document Authoring: Author and review key clinical trial documents, including but not limited to Clinical Study Protocols (CSPs), Investigator’s Brochures (IBs), Clinical Study Reports (CSRs), and Informed Consent Forms (ICFs).
- Clinical Data Review & Signal Evaluation: Lead ongoing scientific and medical data review, analyzing emerging safety signals, evaluating lab trends, assessing protocol compliance, and drafting data summaries for medical oversight.
- Trial Design & Endpoint Strategy: Conduct literature reviews and evaluate clinical data to support scientific rationales, select robust primary/secondary/exploratory study endpoints, and refine study design strategies.
- Cross-Functional Partnership: Serve as the primary scientific liaison for clinical trial site/s, CROs, and external investigators while collaborating closely with Medical Directors, Clinical Operations, Clinical Pharmacology, Biostatistics, and Regulatory Affairs.
- Regulatory & Scientific Dissemination: Author and review clinical components of regulatory submissions (INDs, CTAs, NDAs/BLAs) and contribute to scientific abstracts, manuscripts, and conference presentations.
- Governance & Oversight: Prepare for and present scientific data during Data Safety Monitoring Board (DSMB) meetings, Advisory Board meetings, and Investigator Meetings.

## Qualifications

- Education: Scientific degree (BS), Advanced degree preferred (MS, PharmD or equivalent) in Biology, Immunology, Biochemistry, Pharmacology, Pharmaceutical Sciences, or a related scientific/healthcare field.
- Experience: 8+ years of clinical research experience within the biopharmaceutical industry, CROs, or academic clinical trial centers, with a track record of supporting trial execution.
- Expertise: Deep understanding of clinical trial methodology, biostatistical concepts, GCP/ICH guidelines, and medical data review tools (e.g., Spotfire, JReview, Medidata Rave).
- Communication: Exceptional oral and written communication skills, with a proven ability to translate complex clinical data into clear scientific documents and stakeholder presentations.
- Mindset: A collaborative and adaptable team player who thrives in a fast-paced environment and excels at managing cross-functional dependencies.

Benefits:

Superluminal offers a comprehensive benefits package that fully covers employees’ annual deductibles and monthly premiums for medical, dental, and vision insurance. The package also includes a 401(k) match program, a Massachusetts transportation subsidy, equity, unlimited paid time off, and both disability and life insurance.

Equal Opportunity Statement:

Superluminal Medicines is an Equal Opportunity Employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status.

## About Superluminal Medicines, Inc.

## Company Overview
- **One-liner**: Superluminal Medicines is a drug discovery company integrating AI/ML, protein dynamics, and structural biology to rapidly develop small molecule therapeutics targeting challenging G protein-coupled receptors (GPCRs) for cardiometabolic diseases and obesity.
- **Entity Type**: Private (Convertible Note financing round; total funding $158M as of 2026)
- **Headquarters**: Boston, Massachusetts, United States (15 Necco Street, 4th Floor)
- **Founded**: 2022
- **Founders**: Not publicly disclosed

## Core Business
- **Primary Industry**: Biotechnology / Drug Discovery & Development
- **Target Customers**: B2B partnerships with large pharmaceutical companies (e.g., Eli Lilly) and, ultimately, patients with cardiometabolic conditions and obesity
- **Mission / Purpose**: “Revolutionizing the speed and accuracy of how medicine is created” by combining generative biology and chemistry with AI-driven computational methods.

## Products & Services
- **Hyperloop™ Platform**: An integrated drug discovery platform that merges structure-based drug discovery, machine learning, proprietary big data infrastructure, and experimental validation to generate candidate-ready small molecule compounds targeting GPCRs. (SaaS/internal tool – not sold externally)
- **Pipeline – MC4R Agonist**: A selective, biased MC4R agonist advancing to IND-enabling studies for the treatment of obesity.
- **Other pipeline programs**: Undisclosed GPCR targets for cardiometabolic diseases, developed in collaboration with Eli Lilly.

## Market Standing
- **Valuation**: Not publicly available
- **Key Metric**: Total funding raised – $158M (CB Insights estimate)
- **Notable Investors/Partners**: Eli Lilly and Company (collaborator and equity investor), RA Capital Management, Insight Partners, Gaingels, NVentures (NVIDIA’s venture arm)
- **Growth Signals**:
  - Announced a multi-target collaboration with Eli Lilly worth up to $1.3B in upfront, near-term, milestone payments, equity investment, and tiered royalties.
  - Biased MC4R agonist moving into IND-enabling studies.
  - Active hiring: 5+ open positions in Machine Learning, Protein Design, Computational Chemistry, HR, and Finance.

## Competitive Advantages
- **Hyperloop Platform**: Combines deep biology/chemistry expertise with AI and proprietary big data in a single, rapid iteration cycle – enabling candidate-ready compounds at unprecedented speed.
- **GPCR Focus**: Specialization in the most challenging GPCR targets, a proven class for drug development but historically difficult to modulate selectively.
- **Big Pharma Backing**: Strategic collaboration with Eli Lilly provides significant funding, validation, and potential for rapid clinical development.

## Strategic Focus
- Advance the MC4R agonist and other pipeline candidates through IND-enabling studies and into clinical trials.
- Expand the Hyperloop platform’s application to additional GPCR targets and disease areas beyond cardiometabolic indications.
- Leverage AI/ML and structural biology to compress traditional drug discovery timelines from years to months.

## Why Work Here
- **Culture**: Core values emphasize urgency (speed to patients), resilience, collaboration, transparency, and compassion. The team describes the environment as inclusive, collaborative, and supportive.
- **Work Policy**: Primarily onsite at a brand-new lab space in Boston’s Seaport area (Lilly Gateway Labs). Remote/hybrid flexibility is not explicitly stated.
- **Benefits**: 100% employer-paid health/dental/vision insurance, equity participation, 401k, unlimited paid time off, and a subsidy for parking or mass transit.
- **Engineering & Science Culture**: Opportunities to work at the intersection of AI/ML, computational chemistry, and structural biology in a well-funded, fast-moving biotech startup with direct pharma partnerships.

## Sources
1. [superluminalrx.com](https://www.superluminalrx.com/about/)
2. [superluminalrx.com](https://www.superluminalrx.com/careers/)
3. [cbinsights.com](https://www.cbinsights.com/company/superluminal-medicines)
4. [job-boards.greenhouse.io](https://job-boards.greenhouse.io/superluminalrx)

## Other roles at Superluminal Medicines, Inc.

- [Facilities Manager](https://feeny.ai/job/facilities-manager-superluminal-medicines-inc-boston-8nq8khwhqgzr) — Boston, MA
- [Director, Technical Accounting & External Financial Reporting](https://feeny.ai/job/director-technical-accounting-external-financial-reporting-superluminal-49bbyadb2w2t) — Boston, MA
- [Research Associate/ Senior Research Associate, Discovery Biology](https://feeny.ai/job/research-associate-senior-research-associate-discovery-biology-superluminal-m37r6n23bkv2) — Boston, MA
- [Scientist-Principal Scientist, Protein Design & Structure](https://feeny.ai/job/scientist-principal-scientist-protein-design-structure-superluminal-medicines-jf2p40h4fwng) — Boston, MA
- [Senior Scientist - Principal Scientist, Computational Chemistry](https://feeny.ai/job/senior-scientist-principal-scientist-computational-chemistry-superluminal-amgvtc3fygv1) — Boston, MA